Literature DB >> 4298943

Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.

M A Newton, J H Laragh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4298943     DOI： 10.1210/jcem-28-7-1014

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  11 in total

1.  Acute alteration of plasma renin activity by large doses of intravenous prednisolone.

Authors:  F H Katz; M M Popovtzer; W F Pinggera; C G Halgrimson; T E Starzl
Journal:  Proc Soc Exp Biol Med       Date:  1972-12

2.  Variations in arterial blood pressure after kidney transplantation. Relation to renal function, plasma renin activity, and the dose of prednisone.

Authors:  M M Popovtzer; W Pinnggera; F H Katz; J L Corman; J Roninette; B Lanois; C G Haglrimson; T E Starzel
Journal:  Circulation       Date:  1973-06       Impact factor: 29.690

Review 3.  [Regulation of aldosterone secretion].

Authors:  C Werning; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1971-04-01

4.  Non-tumorous "primary" aldosteronism. I. Type relieved by glucocorticoid (glucocorticoid-remediable aldosteronism).

Authors:  I S Salti; M Stiefel; J L Ruse; J C Laidlaw
Journal:  Can Med Assoc J       Date:  1969-07-12       Impact factor: 8.262

5.  [Diurnal profiles of plasma aldosterone, cortisol, renin, angiotensinogen and angiotensinases in normal subjects (author's transl)].

Authors:  D Lommer; A Distler; H P Nast; K Sinterhauf; U Walter; H P Wolff; K Sieler
Journal:  Klin Wochenschr       Date:  1976-02-01

6.  Potassium metabolism in patients with rheumatoid arthritis. Effects of treatment with depot tetracosactrin, spironolactone, and oral supplements of potassium chloride.

Authors:  G Nuki; K Boddy; A C Kennedy; P King; A M Duncan; W W Buchanan
Journal:  Ann Rheum Dis       Date:  1975-12       Impact factor: 19.103

7.  Plasma renin activity following renal transplantation.

Authors:  M H Snow; S J Jachuck; V Robson; R Wilkinson
Journal:  Postgrad Med J       Date:  1978-05       Impact factor: 2.401

8.  Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.

Authors:  D C Kem; M H Weinberger; C Gomez-Sanchez; N J Kramer; R Lerman; S Furuyama; C A Nugent
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

9.  Response to Letter on use of functional imaging by 11C-metomidate PET for primary aldosteronism subtyping.

Authors:  Minna Soinio; Anna-Kaarina Luukkonen; Marko Seppänen; Jukka Kemppainen; Janne Seppänen; Juha-Pekka Pienimäki; Helena Leijon; Tiina Vesterinen; Johanna Arola; Eila Lantto; Semi Helin; Ilkka Tikkanen; Saara Metso; Tuomas Mirtti; Ilkka Heiskanen; Leena Norvio; Mirja Tiikkainen; Tuula Tikkanen; Timo Sane; Matti Välimäki; Celso E Gomez-Sanchez; Ilkka Pörsti; Pirjo Nuutila; Pasi I Nevalainen; Niina Matikainen
Journal:  Eur J Endocrinol       Date:  2021-03       Impact factor: 6.664

10.  Role of endogenous ACTH on circadian aldosterone rhythm in patients with primary aldosteronism.

Authors:  Takuhiro Sonoyama; Masakatsu Sone; Naohisa Tamura; Kyoko Honda; Daisuke Taura; Katsutoshi Kojima; Yorihide Fukuda; Naotetsu Kanamoto; Masako Miura; Akihiro Yasoda; Hiroshi Arai; Hiroshi Itoh; Kazuwa Nakao
Journal:  Endocr Connect       Date:  2014-12       Impact factor: 3.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.